Asia Pacific Recombinant Proteins Market Size is USD 894.28 Million in 2026

Asia Pacific Recombinant Proteins Market (By Product: Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Recombinant Regulatory Protein, Hormones, Others; By Application: Drug Discovery & Development, Therapeutics, Biologics, Research, Others; By End Use: Pharma & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Others; By Host Cell: Mammalian Systems, Insect Cells, Yeast & Fungi, Bacterial Cells, Others) Industry Size, Share, Growth, Trends, 2026 to 2035.

Report Code : 1078 | Published : 22 May 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 790 Mn

Forecast Year,

USD 2,729.55 Mn

CAGR, 2026 - 2035

13.20%

Report Coverage

Asia Pacific

Download Databook

The Asia Pacific recombinant proteins market size was estimated at USD 790.00 million in 2025 and is projected to be worth around USD 2,729.55 million by 2035, expanding at a CAGR of 13.20% from 2026 to 2035.

Asia Pacific Recombinant Proteins Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 790.00 Million
Market Size in 2026	USD 894.28 Million
Market Size by 2035	USD 2,729.55 Million
CAGR 2026 to 2035	13.20%
Base Year	2025
Forecast Period	2026 to 2035

The growth of the recombinant proteins market is driven by the rapidly growing biotechnology sector, increasing healthcare expenditure, and rising burden of chronic diseases. Government initiatives and funding supporting research and development for recombinant protein studies and favourable government regulations, along with expanding pharmaceutical manufacturing capabilities, are significantly boosting demand across the Asia Pacific.

Countries like China and India are emerging as manufacturing hubs. Affordable production, increasing outsourcing, and growing clinical research activities are encouraging global companies to expand partnerships within the Asia Pacific.

Segments	Shares (%)
Antibodies	28%
Cytokines & Growth Factors	20%
Enzymes	12%
Hormones	11%
Recombinant Regulatory Protein	9%
Immune Checkpoint Proteins	8%
Virus Antigens	7%
Others	5%

Cytokines & Growth Factors - Cytokines & Growth Factors hold a significant portion, with a share of 20%, supported by increasing use in regenerative medicine, oncology research, and cell signalling studies.
Antibodies - Antibodies lead the segment, with a share of 28%, driven by strong demand in biologics development, immunotherapy, and targeted therapeutic research applications.
Enzymes - Enzymes account for a notable share, with a share of 12%, driven by applications in drug discovery, diagnostics, and industrial biotechnology processes.

Segments	Shares (%)
Pharma & Biotechnology Companies	55%
Academic & Research Institutes	25%
Diagnostic Laboratories	15%
Others	5%

Pharma & Biotechnology Companies - Pharma & Biotechnology Companies lead the segment, with a share of 55%, driven by strong R&D investments and widespread adoption in biologics and drug discovery pipelines.
Academic & Research Institutes - Academic & Research Institutes hold a significant portion, with a share of 25%, supported by continuous innovation in molecular biology and protein engineering research.
Others - Others represent a smaller share, with a share of 5%, reflecting niche industrial and research applications.

Segments	Shares (%)
Mammalian Systems	60%
Mammalian Systems	50%
Yeast & Fungi	16%
Insect Cells	15%
Bacterial Cells	14%
Others	5%

Mammalian systems - Mammalian systems dominate the segment, with a share of 60%, driven by their ability to produce complex, biologically active human-like proteins with proper folding.
Insect Cells - Insect Cells represent a smaller share, with a share of 15%, supported by use in vaccine development and specialized protein expression.
Yeast & Fungi - Yeast & Fungi account for a notable share, with a share of 16%, driven by efficiency and suitability for industrial-scale recombinant protein production.

Top Companies in the Asia Pacific Recombinant Proteins Market

Sino Biological, Inc.
Bio-Techne
GenScript
Bio-Rad Laboratories, Inc.
Merck KGaA
Thermo Fisher Scientific
Proteintech Group, Inc.
Enzo Life Sciences, Inc.
Abnova Corporation
RayBiotech Life Inc.
STEMCELL Technologies Inc.

Segments Covered in the Report

By Product

Cytokines & Growth Factors
- Interferons (IFNs)
- Interleukins (ILs)
- Others
Antibodies
Immune checkpoint proteins
Virus Antigens
- Enzymes
- Kinases
- Metabolic enzymes
- Others
Recombinant Regulatory Protein
Hormones
Others

By Application

Drug Discovery & Development
Therapeutics
- Biologics
- Vaccines
- Cell & Gene Therapies
- Others
Research
Others

By End Use

Pharma & Biotechnology Companies
Academic & Research Institutes
Diagnostic Laboratories
Others

By Host Cell

Mammalian systems
Insect Cells
Yeast & Fungi
Bacterial Cells
Others

List of Tables & Figures

List of Tables

Table 1: Asia Pacific Recombinant Proteins Market Size, Product, 2025-2035 (USD Million)
Table 2: Asia Pacific Cytokines & Growth Factors Market Size, 2025-2035 (USD Million)
Table 3: Asia Pacific Antibodies Market Size, 2025-2035 (USD Million)
Table 4: Asia Pacific Immune Checkpoint Proteins Market Size, 2025-2035 (USD Million)
Table 5: Asia Pacific Virus Antigens Market Size, 2025-2035 (USD Million)
Table 6: Asia Pacific Recombinant Regulatory Protein Market Size, 2025-2035 (USD Million)
Table 7: Asia Pacific Hormones Market Size, 2025-2035 (USD Million)
Table 8: Asia Pacific Others Product Market Size, 2025-2035 (USD Million)
Table 9: Asia Pacific Recombinant Proteins Market Size, Application, 2025-2035 (USD Million)
Table 10: Asia Pacific Drug Discovery & Development Market Size, 2025-2035 (USD Million)
Table 11: Asia Pacific Therapeutics Market Size, 2025-2035 (USD Million)
Table 12: Asia Pacific Biologics Market Size, 2025-2035 (USD Million)
Table 13: Asia Pacific Research Market Size, 2025-2035 (USD Million)
Table 14: Asia Pacific Others Application Market Size, 2025-2035 (USD Million)
Table 15: Asia Pacific Recombinant Proteins Market Size, End Use, 2025-2035 (USD Million)
Table 16: Asia Pacific Pharma & Biotechnology Companies Market Size, 2025-2035 (USD Million)
Table 17: Asia Pacific Academic & Research Institutes Market Size, 2025-2035 (USD Million)
Table 18: Asia Pacific Diagnostic Laboratories Market Size, 2025-2035 (USD Million)
Table 19: Asia Pacific Others End Use Market Size, 2025-2035 (USD Million)
Table 20: Asia Pacific Recombinant Proteins Market Size, Host Cell, 2025-2035 (USD Million)
Table 21: Asia Pacific Mammalian Systems Market Size, 2025-2035 (USD Million)
Table 22: Asia Pacific Insect Cells Market Size, 2025-2035 (USD Million)
Table 23: Asia Pacific Yeast & Fungi Market Size, 2025-2035 (USD Million)
Table 24: Asia Pacific Bacterial Cells Market Size, 2025-2035 (USD Million)
Table 25: Asia Pacific Others Host Cell Market Size, 2025-2035 (USD Million)
Table 26: China Recombinant Proteins Market Size, 2025-2035 (USD Million)
Table 27: Japan Recombinant Proteins Market Size, 2025-2035 (USD Million)
Table 28: South Korea Recombinant Proteins Market Size, 2025-2035 (USD Million)
Table 29: India Recombinant Proteins Market Size, 2025-2035 (USD Million)
Table 30: Southeast Asia Recombinant Proteins Market Size, 2025-2035 (USD Million)
Table 31: Asia Pacific Market Share, Product, 2025 (%)
Table 32: Asia Pacific Market Share, Application, 2025 (%)
Table 33: Asia Pacific Market Share, End Use, 2025 (%)
Table 34: Asia Pacific Market Share, Host Cell, 2025 (%)

List of Figures

Figure 1: Asia Pacific Recombinant Proteins Market Share, Product, 2025 (%)
Figure 2: Asia Pacific Recombinant Proteins Market Share, Application, 2025 (%)
Figure 3: Asia Pacific Recombinant Proteins Market Share, End Use, 2025 (%)
Figure 4: Asia Pacific Recombinant Proteins Market Share, Host Cell, 2025 (%)
Figure 5: Asia Pacific Recombinant Proteins Market Forecast, 2025-2035 (USD Million)
Figure 6: Asia Pacific Cytokines & Growth Factors Market Forecast, 2025-2035 (USD Million)
Figure 7: Asia Pacific Antibodies Market Forecast, 2025-2035 (USD Million)
Figure 8: Asia Pacific Immune Checkpoint Proteins Market Forecast, 2025-2035 (USD Million)
Figure 9: Asia Pacific Virus Antigens Market Forecast, 2025-2035 (USD Million)
Figure 10: Asia Pacific Recombinant Regulatory Protein Market Forecast, 2025-2035 (USD Million)
Figure 11: Asia Pacific Hormones Market Forecast, 2025-2035 (USD Million)
Figure 12: Asia Pacific Others Product Market Forecast, 2025-2035 (USD Million)
Figure 13: Asia Pacific Drug Discovery & Development Market Forecast, 2025-2035 (USD Million)
Figure 14: Asia Pacific Therapeutics Market Forecast, 2025-2035 (USD Million)
Figure 15: Asia Pacific Biologics Market Forecast, 2025-2035 (USD Million)
Figure 16: Asia Pacific Research Market Forecast, 2025-2035 (USD Million)
Figure 17: Asia Pacific Pharma & Biotechnology Companies Market Forecast, 2025-2035 (USD Million)
Figure 18: Asia Pacific Academic & Research Institutes Market Forecast, 2025-2035 (USD Million)
Figure 19: Asia Pacific Diagnostic Laboratories Market Forecast, 2025-2035 (USD Million)
Figure 20: Asia Pacific Mammalian Systems Market Forecast, 2025-2035 (USD Million)
Figure 21: Asia Pacific Insect Cells Market Forecast, 2025-2035 (USD Million)
Figure 22: Asia Pacific Yeast & Fungi Market Forecast, 2025-2035 (USD Million)
Figure 23: Asia Pacific Bacterial Cells Market Forecast, 2025-2035 (USD Million)
Figure 24: China Recombinant Proteins Market Forecast, 2025-2035 (USD Million)
Figure 25: Japan Recombinant Proteins Market Forecast, 2025-2035 (USD Million)
Figure 26: South Korea Recombinant Proteins Market Forecast, 2025-2035 (USD Million)
Figure 27: India Recombinant Proteins Market Forecast, 2025-2035 (USD Million)
Figure 28: Southeast Asia Recombinant Proteins Market Forecast, 2025-2035 (USD Million)

Research Methodology

Related Databooks

March 2026